Aurobindo Pharma Ltd (AUROPHARMA) — Announcement | 21 September 2026
Aurobindo Pharma announced its participation in a JP Morgan Healthcare Trip investor meeting in Hyderabad on September 24, 2026, from 2:30 to 3:30 PM IST, confirming officials will attend without discussing any unpublished price-sensitive information.
About Aurobindo Pharma Ltd (AUROPHARMA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when AUROPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AUROPHARMA — Free💡 Ask AI about this filing
📊 More AUROPHARMA filings
- Announcement — 24 September 2026Aurobindo Pharma announced that its trading window will close on October 1, 2026, for all designated...
- 🔴 Announcement — 15 September 2026Aurobindo Pharma announced USFDA final approval for its first metered-dose inhaler, Beclomethasone D...
- 🔴 Announcement — 15 September 2026Aurobindo Pharma announced the completion of a US FDA inspection at its Apitoria Pharma subsidiary's...
- 🔴 Corporate Action — 12 September 2026Aurobindo Pharma announced its step-down subsidiary A1 Biochem Labs (India) acquired 100% of newly i...
- 🔴 Announcement — 11 September 2026Aurobindo Pharma announced that the US FDA completed an inspection of its wholly owned subsidiary Ap...
🔥 Also filed on 21 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AUROPHARMA files new disclosures
Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AUROPHARMA — FreeFree account · 2 AI queries/day